Publications by authors named "C Cotteret"
Comparison of two different stretching strategies to improve hip extension mobility in healthy and active adults: a crossover clinical trial.
BMC Musculoskelet Disord
October 2024
Article Synopsis
- A study was conducted to compare the effectiveness of a traditional hip extension stretch versus a new technique involving posterior pelvic tilt to improve hip flexor flexibility in 26 healthy individuals.
- The results showed that the posterior pelvic tilt stretch significantly reduced hip reactive flexor force compared to the conventional stretch, with a noteworthy mean difference in performance.
- However, both techniques did not show any significant impact on active knee extension flexibility.
Background: Femoroacetabular impingement syndrome (FAIS) significantly affects the physical function and quality of life of the young and middle-aged population. Pelvic tilt and trunk muscle endurance are physical features poorly studied in FAIS.
Aim: This study aimed to compare the anterior pelvic tilt and anterior, lateral, and posterior trunk muscles endurance between people with FAIS and healthy individuals, within FAIS sub types and between the symptomatic and asymptomatic hip in people with FAIS.
There are more than 170 known species of non-tuberculous mycobacteria, and some are responsible for serious diseases in people infected with them. One of these is Buruli ulcers, a neglected tropical disease endemic in more than 33 countries and caused by , which infects skin tissue. Treatment consists of a long-term regimen combining the use of oral rifampin with another anti-tuberculosis drug (e.
View Article and Find Full Text PDFBackground: Rituximab (RTX) resistance or early B-cells repopulation were observed in children but only few publications reported the use of Obinutuzumab and no recommendations were made concerning the dosage for children.
Methods: This study was a single-center retrospective cohort study of all the children followed-up in the Pediatric Neurology Department of Necker-Enfants malades Hospital in Paris, France, and treated with obinutuzumab, between November 1, 2019, and November 1, 2021.
Results: A total of eight children (three females, median age 4.
Article Synopsis
- Researchers tested a cream containing paromomycin (with or without gentamicin) on travelers with cutaneous leishmaniasis (CL), achieving cure rates of 75-82%, comparable to clinical trials.
- Two groups were studied: one treated under supervision (Group 1) and another using a locally produced paromomycin-only cream (Group 2), both showing similar medical outcomes despite some differences in cure rates.
- Adverse effects were mostly mild, with common issues being itching and pain, and no serious complications or mucosal involvement occurred throughout the study.